NDC 71335-1378 – Buprenorphine and Naloxone

Buprenorphine 8 mg/1; Naloxone 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-1378

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205022
Marketed since
September 19, 2016
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1378-042 TABLET in 1 BOTTLE (71335-1378-0)May 20, 2024
71335-1378-130 TABLET in 1 BOTTLE (71335-1378-1)Oct 25, 2019
71335-1378-260 TABLET in 1 BOTTLE (71335-1378-2)May 20, 2024
71335-1378-390 TABLET in 1 BOTTLE (71335-1378-3)May 20, 2024
71335-1378-4120 TABLET in 1 BOTTLE (71335-1378-4)May 20, 2024
71335-1378-514 TABLET in 1 BOTTLE (71335-1378-5)May 20, 2024
71335-1378-628 TABLET in 1 BOTTLE (71335-1378-6)May 20, 2024
71335-1378-76 TABLET in 1 BOTTLE (71335-1378-7)May 20, 2024
71335-1378-810 TABLET in 1 BOTTLE (71335-1378-8)May 20, 2024
71335-1378-921 TABLET in 1 BOTTLE (71335-1378-9)May 20, 2024

Other Buprenorphine and Naloxone products